Gossamer Bio, Inc. (GOSS)
2.26
-0.18
(-7.19%)
USD |
NASDAQ |
Feb 06, 16:00
2.295
+0.04
(+1.55%)
Pre-Market: 08:03
Gossamer Bio Total Assets (Quarterly) : 208.82M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Madrigal Pharmaceuticals, Inc. | 1.362B |
| XOMA Royalty Corp. | 263.15M |
| Rezolute, Inc. | 158.66M |
| Axsome Therapeutics, Inc. | 669.25M |
| Crinetics Pharmaceuticals, Inc. | 1.196B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 291.15M |
| Shareholders Equity (Quarterly) | -82.33M |
| Debt to Equity Ratio | -2.464 |
| Current Ratio | 3.284 |
| Net Debt Paydown Yield | -0.13% |